Therapeutic Asset Ratings

686 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
LENVATINIB Breast Cancer	Jiuda Zhao	P3	BB (65)
Alpelisib Breast Cancer	M.D. Anderson Cancer Center	P4	BB (64)
Daunorubicin Breast Cancer	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	P4	BB (64)
Denosumab Breast Cancer	Alliance for Clinical Trials in Oncology	P4	BB (64)
FENTANYL Breast Cancer	Aga Khan University	P4	BB (64)
Metformin Breast Cancer	City of Hope Medical Center	P4	BB (64)
Olaparib Breast Cancer	The Netherlands Cancer Institute	P4	BB (64)
Rivoceranib Breast Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P4	BB (64)
ROPIVACAINE Breast Cancer	Aldy Aldy	P4	BB (64)
Trastuzumab Deruxtecan Breast Cancer	SWOG Cancer Research Network	P4	BB (64)
Tucidinostat Breast Cancer	Beijing 302 Hospital	P4	BB (64)
Lapatinib Breast Cancer	University of New Mexico	P3	BB (64)
CISATRACURIUM ION Breast Cancer	University of Rijeka	P4	B (63)
Desflurane Breast Cancer	University of Rijeka	P4	B (63)
MIDAZOLAM Breast Cancer	Jun Zhang	P4	B (63)
Pregabalin Breast Cancer	Jules Bordet Institute	P4	B (63)
Pyrotinib Breast Cancer	Fudan University	P4	B (63)
Rosuvastatin Breast Cancer	Shiraz University of Medical Sciences	P4	B (63)
SUFENTANIL CITRATE Breast Cancer	University of Rijeka	P4	B (63)
Toripalimab Breast Cancer	Zhejiang Cancer Hospital	P4	B (63)
Atirmociclib Breast Cancer	AstraZeneca	P3	B (63)
Giredestrant Breast Cancer	Genentech, Inc.	P3	B (63)
Hrs-8080 Breast Cancer	Shandong Suncadia Medicine Co., Ltd.	P3	B (63)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide Breast Cancer	Sichuan Baili Pharmaceutical Co., Ltd.	P3	B (63)
Isosulfan blue Breast Cancer	University of Wisconsin, Madison	P3	B (63)

Showing 51 to 75 of 686 assets

PreviousPage 3 of 28Next